Cellectis S.A. Research and Development Expense
Cellectis S.A. (CLLS) reported Research and Development Expense of $93.52 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-20
- Cellectis S.A. research and development expense for the quarter ending 2025-06-30 was $23.08M, a 1.86% decline year-over-year.
- Cellectis S.A. research and development expense for the quarter ending 2024-06-30 was $23.52M, a 5.94% increase year-over-year.
- Cellectis S.A. research and development expense for the quarter ending 2023-06-30 was $22.20M, a 13.38% decline year-over-year.
- Cellectis S.A. research and development expense for the quarter ending 2022-06-30 was $25.63M, a 17.71% decline year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $93.52M 20-F · filed 2026-03-20 | |||||
| 2025-06-30 | $23.08M 6-K/A · filed 2025-10-14 | $45.01M 6-K/A · filed 2025-10-14 | ||||
| 2024-12-31 | $90.54M 20-F · filed 2026-03-20 | |||||
| 2024-06-30 | $23.52M 6-K/A · filed 2025-10-14 | $45.84M 6-K/A · filed 2025-10-14 | ||||
| 2023-12-31 | $87.65M 20-F · filed 2026-03-20 | |||||
| 2023-06-30 | $22.20M 6-K/A · filed 2024-09-11 | $22.14M 6-K/A · filed 2023-09-05 | $43.61M 6-K/A · filed 2024-09-11 | $43.23M 6-K/A · filed 2023-09-05 | ||
| 2022-12-31 | $97.50M 20-F · filed 2025-03-14 | |||||
| 2022-06-30 | $25.63M 6-K/A · filed 2023-09-05 | $29.05M 6-K/A · filed 2022-08-31 | $52.23M 6-K/A · filed 2023-09-05 | $58.53M 6-K/A · filed 2022-08-31 | ||
| 2021-12-31 | $117.84M 20-F · filed 2024-04-29 | $129.03M 20-F · filed 2022-03-03 | ||||
| 2021-06-30 | $31.15M 6-K/A · filed 2022-08-31 | $62.34M 6-K/A · filed 2022-08-31 | ||||
| 2020-12-31 | $77.05M 20-F · filed 2023-03-14 | $86.95M 20-F · filed 2021-03-04 | ||||
| 2020-06-30 | $22.86M 6-K/A · filed 2021-08-31 | $43.59M 6-K/A · filed 2021-08-31 | ||||
| 2019-12-31 | $92.04M 20-F · filed 2022-03-03 | |||||
| 2019-06-30 | $25.42M 6-K/A · filed 2020-09-09 | $39.99M 6-K/A · filed 2020-09-09 | ||||
| 2018-12-31 | $76.57M 20-F · filed 2021-03-04 | |||||
| 2017-12-31 | $79.23M 20-F · filed 2020-03-05 | |||||
| 2016-12-31 | $78.46M 20-F · filed 2019-03-12 | |||||
| 2015-12-31 | $58.15M 20-F · filed 2018-03-13 |